Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Pharmexcil
Pharmexcil
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Manufacturing
Contract manufacturing in India grows at 20%
SMEs predicted to be main beneficiaries of this growth
India calls off EU trade talks
Action reflects disappointment at EU ban on 700 Indian-made generics
Pharmaceutical
India and China set to dominate biosimilars market
Annual growth rate for biosimilars in India and China could reach 30% in 2014-18
Regulatory obstacles hinder Indian pharma exports to Vietnam
Companies 'red listed' by Vietnamese drug regulatory authority for regulatory non-compliance
Indian pharma exports could miss growth target
Delays in regulatory approvals in North America could halve expected growth rate
Pharmaceutical
Indian pharma to target eastern Europe
Delegation set to promote generics in Hungary, Czech Republic and Romania
Finance
India pharma exports to touch $25bn by 2018
Ability to supply Argentina a major boost to export growth
Subscribe now